Tag: observational studies

ISPOR Announces Plenary Sessions and Speakers For 22nd Annual International Meeting

Conference to Focus on Timely Theme of Evidence and Value in a Time of Social and Policy Change Princeton, NJ—March 6, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 22nd Annual International

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

The International Society For Pharmacoeconomics And Outcomes Research Examines The Role Of Big Data In Health Care Decision Making

Princeton, NJ, USA – Health care researchers, health technology assessors, manufacturers, governments, and patients will examine the role of “Big Data” in health care decision making at the ISPOR 19th Annual International Meeting. The meeting will take place May 31 – June

Posted in ISPOR News & Press Tagged with: , , , ,

Drug Initiation: Major Issue In Long-Term Adherence To Medication Therapy

Gentofte, Denmark – Poor adherence to long-term medication therapy among patients with a chronic disease is well-known, but the nature of poor adherence over time, at a population level is not well established. Studies from clinical trials have shown that discontinuation is

Posted in Methodological Articles, Value in Health Tagged with: , ,

Does Outcomes Research Reduce Policy Maker Uncertainty?

Rotterdam, The Netherlands – Health care payers increasingly request additional data from clinical practice to assess whether a drug is worth public spending. The data gathered should reduce the initial uncertainty regarding the clinical and economic performance of expensive drugs in a

Posted in Comparative Effectiveness Research / Health Technology Assessment, Value in Health Tagged with: , , , ,

Common Adverse Effects And Health Care Costs In HIV Patients On Antiretroviral Therapies

Washington, DC, USA – Human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system. More than one million people in the United States are affected by HIV. There is currently no cure for HIV; however, antiretroviral therapies such as

Posted in Comparative Effectiveness Research / Health Technology Assessment, Value in Health Tagged with: , , , , , ,